View of Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1: Pathophysiology and key clinical studies

Return to Article Details Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1: Pathophysiology and key clinical studies Download Download PDF